Bearish
TransMedics Group, Inc. (TMDX) has received an average "Moderate Buy" rating from twelve brokerages, with an average 12-month target price of $135.00,...
Neutral
Canaccord Genuity Group has revised its price target for TransMedics Group (NASDAQ:TMDX) down to $124.00 from $152.00, while maintaining a "buy" ratin...
Neutral
Vanguard Capital Management has reported a beneficial ownership of 1,737,137 shares in TransMedics Group Inc (NASDAQ: TMDX), representing a 5.06% stak...
This article discusses the reasons to retain TransMedics stock in a portfolio. It likely covers aspects such as the company's financial performance, m...